Full Text View
Tabular View
No Study Results Posted
Related Studies
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease
This study is ongoing, but not recruiting participants.
Study NCT00516321   Information provided by GlaxoSmithKline
First Received: August 13, 2007   Last Updated: November 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thrombocytopenia
Hepatitis C
Additional conditions recognized in this trial
Hepatitis
More general conditions related to this trial
Blood Platelet Disorders
Digestive System Diseases
Flaviviridae Infections
Hematologic Diseases
Hepatitis, Viral, Human
Liver Diseases
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
eltrombopag
Additional drug interventions recognized in this trial
Antiviral Agents
Peginterferon alfa-2a
More general drug interventions related to this trial
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services